Sherly Mosessian
- Role
- Chief Scientific Officer at SOFIE
- Location
- Glendale, CA, US
- LinkedIn followers
- 500 followers
Experience
Chief Scientific Officer
Apr 2022 — Present
As the Chief Scientific Officer, formulate the strategic plan for scientific objectives of the organization, including establishing the pan-tumor radiopharmaceutical diagnostic clinical development program. Direct all facets of clinical development efforts through FDA approval for SOFIE’s products. Oversee regulatory requirements, including Quality Assurance, and provide leadership in engagements with regulatory entities. Engage and as appropriate, lead interactions with external academic, industry and contract research organizations (CRO), and establish collaborations consistent with internal strategies.
Education
UCLA
PhD, Cancer Research
2004 — 2009
UCLA
B.S, Biochemistry
2004
Skills
- Molecular Biology
- Biotechnology
- Cell Culture
- Clinical Development
- U.s. Food and Drug Administration (Fda)
- Biochemistry
- Clinical Research
- Cell Biology
- Research
- Investigational New Drug Applications
- Clinical Trials
- Chemistry
- Pharmacology
- Lifesciences
- Life Sciences
- Gmp
- Management
- Executive Level Administration
- Translational Research
- Pet Imaging Probes
- Abbreviated New Drug Applications
- Laboratory Skills
- Molecular Imaging
- Fda
- Positron Emission Tomography
- Western Blotting
- Laboratory
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.